摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-diethyl-N'-(2-nitro-phenyl)-propane-1,3-diamine | 46895-63-0

中文名称
——
中文别名
——
英文名称
N,N-diethyl-N'-(2-nitro-phenyl)-propane-1,3-diamine
英文别名
N1,N1-diethyl-N3-(2-nitrophenyl)propane-1,3-diamine;2-Nitro-1-<3-diaethylamino-propylamino>-benzol;N,N-diethyl-N'-(2-nitro-phenyl)-propanediyldiamine;N,N-Diaethyl-N'-(2-nitro-phenyl)-propandiyldiamin;N-[3-(Diethylamino)propyl]-2-nitroaniline;N',N'-diethyl-N-(2-nitrophenyl)propane-1,3-diamine
N,N-diethyl-N'-(2-nitro-phenyl)-propane-1,3-diamine化学式
CAS
46895-63-0
化学式
C13H21N3O2
mdl
MFCD11123369
分子量
251.329
InChiKey
MRDUXQSIYBIIPD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    18
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.538
  • 拓扑面积:
    61.1
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N,N-diethyl-N'-(2-nitro-phenyl)-propane-1,3-diamine 在 5%-palladium/activated carbon 、 氢气 作用下, 以 乙醇 为溶剂, 以43%的产率得到N1-[3-(diethylamino)propyl]-1,2-phenylenediamine
    参考文献:
    名称:
    Riminophenazine 衍生物作为潜在的抗结核药物:合成、生物学和电化学评估
    摘要:
    已经设计并合成了一系列新的 riminophenazine 衍生物,在 N-5 处具有可电离的烷基取代基,并在 C-3 亚氨基氮、C-8 处和侧基芳基上具有多种取代基。使用对结核分枝杆菌H 37 Rv 的体外活性、哺乳动物细胞毒性和循环伏安法测定的化合物的氧化还原电位作为措施,对亲脂性、氧化还原电位和抗分枝杆菌活性之间的关系进行了初步研究。结果显示与 C-8 替代相关的活动“悬崖”(10l和10m),连同定义的氧化还原活性,指出一类新的 riminophenazines 作为具有合理活性 (MIC 99 ~1 µM) 的潜在抗结核剂。
    DOI:
    10.3390/molecules26144200
  • 作为产物:
    参考文献:
    名称:
    The Preparation of Substituted o-Nitranilines
    摘要:
    DOI:
    10.1021/ja01237a008
点击查看最新优质反应信息

文献信息

  • Parallel synthesis of a series of potentially brain penetrant aminoalkyl benzoimidazoles
    作者:Iolanda Micco、Arianna Nencini、Joanna Quinn、Hendrick Bothmann、Chiara Ghiron、Alessandro Padova、Silvia Papini
    DOI:10.1016/j.bmc.2007.11.068
    日期:2008.3
    Alpha7 agonists were identified via GOLD (CCDC) docking in the putative agonist binding site of an alpha7 homology model and a series of aminoalkyl benzoimidazoles was synthesised to obtain potentially brain penetrant drugs. The array was prepared starting from the reaction of ortho-fluoronitrobenzenes with a selection of diamines, followed by reduction of the nitro group to obtain a series of monoalkylated phenylene diamines. N,N'-Carbonyidiimidazole (CDI) mediated acylation, followed by a parallel automated work-up procedure, afforded the monoacylated phenylenediamines which were cyclised under acidic conditions. Parallel work-up and purification afforded the array products in good yields and purities with a robust parallel methodology which will be useful for other libraries. Screening for alpha7 activity revealed compounds with agonist activity for the receptor. (C) 2007 Elsevier Ltd. All rights reserved.
  • Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors
    作者:Bing-Lei Yao、Yan-Wen Mai、Shuo-Bin Chen、Hua-Ting Xie、Pei-Fen Yao、Tian-Miao Ou、Jia-Heng Tan、Hong-Gen Wang、Ding Li、Shi-Liang Huang、Lian-Quan Gu、Zhi-Shu Huang
    DOI:10.1016/j.ejmech.2015.01.024
    日期:2015.3
    A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549). These compounds were found to be dual inhibitors of topoisomerase (Topo) I and Topo II, and exhibited excellent antiproliferative activity, in particular against HL-60 cells with submicromolar IC50 values. Further mechanistic studies showed that this class of compounds acted as Topo I poisons by stabilizing the Topo I-DNA cleavage complexes and Topo II catalytic inhibitors by inhibiting the ATPase activity of hTopo II. Molecular docking studies revealed the binding modes of these compounds for Topo I and Topo II. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • 183. Structure and antimalarial activity. Part I. Some acridine derivatives
    作者:D. Muriel Hall、E. E. Turner
    DOI:10.1039/jr9450000694
    日期:——
  • 492. Inhibitors of flavoprotein enzymes
    作者:R. B. Barlow
    DOI:10.1039/jr9510002225
    日期:——
  • 9-(Dialkylaminoalkyl)-isoalloxazines
    作者:Frank Kipnis、Nathan Weiner、Paul E. Spoerri
    DOI:10.1021/ja01196a016
    日期:1947.4
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐